539
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Update on the prevalence and determinants of folic acid use in Japan evaluated with 91,538 pregnant women: the Japan Environment and Children’s Study

ORCID Icon, , , , , , , , , , , , , , , & show all
Pages 427-436 | Received 17 Mar 2018, Accepted 26 Jun 2018, Published online: 19 Aug 2018

References

  • MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet. 1991;338(8760):131–137.
  • De Wals P, Tairou F, Van Allen MI, et al. Reduction in neural-tube defects after folic acid fortification in Canada. N Engl J Med. 2007;357(2):135–142.
  • US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, et al. Folic acid supplementation for the prevention of neural tube defects: US Preventive Services Task Force Recommendation Statement. JAMA. 2017;317(2):183–189.
  • Werler MM, Louik C, Mitchell AA. Achieving a public health recommendation for preventing neural tube defects with folic acid. Am J Public Health. 1999;89(11):1637–1640.
  • Food Fortification Initiative. Global progress; [cited 2018 Mar 17]. Available from: http://www.ffinetwork.org/global_progress/.
  • Mills JL, Signore C. Neural tube defect rates before and after food fortification with folic acid. Birth Defects Res A Clin Mol Teratol. 2004;70(11):844–845.
  • International clearinghouse for birth defects surveillance and research. Annual Report 2014; [cited 2018 Mar 17]. Available from: http://www.icbdsr.org/wp-content/annual_report/Report2014.pdf.
  • Smith MA, Lau C. A resolution on folic acid fortification. Birth Defects Res A Clin Mol Teratol. 2015;103(1):1–2.
  • Kondo A, Morota N, Date H, et al. Awareness of folic acid use increases its consumption, and reduces the risk of spina bifida. Br J Nutr. 2015;114(1):84–90.
  • Kawamoto T, Nitta H, Murata K, et al. Rationale and study design of the Japan environment and children’s study (JECS). BMC Public Health. 2014;14:25.
  • Obara T, Nishigori H, Nishigori T, et al. Prevalence and determinants of inadequate use of folic acid supplementation in Japanese pregnant women: the Japan Environment and Children’s Study (JECS). J Matern Fetal Neonatal Med. 2017;30(5):588–593.
  • Michikawa T, Nitta H, Nakayama SF, et al. Baseline profile of participants in the Japan Environment and Children’s Study (JECS). J Epidemiol. 2018;28(2):99–104.
  • Shaw GM, Schaffer D, Velie EM, et al. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology. 1995;6(3):219–226.
  • Nilsen RM, Leoncini E, Gastaldi P, et al. Prevalence and determinants of preconception folic acid use: an Italian multicenter survey. Ital J Pediatr. 2016;42(1):65.
  • Xing XY, Tao FB, Hao JH, et al. Periconceptional folic acid supplementation among women attending antenatal clinic in Anhui, China: data from a population-based cohort study. Midwifery. 2012;28(3):291–297.
  • Timmermans S, Jaddoe VW, Mackenbach JP, et al. Determinants of folic acid use in early pregnancy in a multi-ethnic urban population in the Netherlands: the Generation R study. Prev Med. 2008;47(4):427–432.
  • Nilsen RM, Vollset SE, Gjessing HK, et al. Patterns and predictors of folic acid supplement use among pregnant women: the Norwegian Mother and Child Cohort Study. Am J Clin Nutr. 2006;84(5):1134–1141.
  • Forster DA, Wills G, Denning A, et al. The use of folic acid and other vitamins before and during pregnancy in a group of women in Melbourne, Australia. Midwifery. 2009;25(2):134–146.
  • de Jong-Van den Berg LT, Hernandez-Diaz S, Werler MM, et al. Trends and predictors of folic acid awareness and periconceptional use in pregnant women. Am J Obstet Gynecol. 2005;192(1):121–128.
  • Tort J, Lelong N, Prunet C, et al. Maternal and health care determinants of preconceptional use of folic acid supplementation in France: results from the 2010 National Perinatal Survey. BJOG. 2013;120(13):1661–1667.
  • Toivonen KI, Oinonen KA, Duchene KM. Preconception health behaviours: a scoping review. Prev Med. 2017;96:1–15.
  • Nishigori H, Obara T, Nishigori T, et al. Drug use before and during pregnancy in Japan: the Japan environment and Children’s Study. Pharmacy. 2017;5(2):21.
  • Morin P, De Wals P, St-Cyr-Tribble D, et al. Pregnancy planning: a determinant of folic acid supplements use for the primary prevention of neural tube defects. Can J Public Health. 2002;93(4):259–263.
  • Feldkamp M, Friedrichs M, Marti K. Folic acid awareness, knowledge, and consumption among women of childbearing age in Utah, 1998–2000. Am J Med Genet. 2002;107(1):67–69.
  • Kondo A, Yamamoto S, Inoue H, et al. Folic acid in the prevention of neural tube defects: awareness among laywomen and healthcare providers in Japan. Congenit Anom (Kyoto). 2009;49(3):97–101.
  • Matsuo T, Kagohashi Y, Senga Y, et al. Survey on awareness of folic acid recognition and intake by female students. Congenit Anom (Kyoto). 2017;57(5):166–170.
  • Yerby MS. Management issues for women with epilepsy: neural tube defects and folic acid supplementation. Neurology. 2003;61(6 Suppl 2):S23–S26.
  • Makol A, Wright K, Amin S. Rheumatoid arthritis and pregnancy: safety considerations in pharmacological management. Drugs. 2011;71(15):1973–1987.
  • McDonnell R, Johnson Z, Doyle A, et al. Determinants of folic acid knowledge and use among antenatal women. J Public Health Med. 1999;21(2):145–149.
  • Sen S, Manzoor A, Deviasumathy M, et al. Maternal knowledge, attitude and practice regarding folic acid intake during the periconceptional period. Public Health Nutr. 2001;4(4):909–912.
  • Cleves MA, Hobbs CA, Collins HB, et al. Folic acid use by women receiving routine gynecologic care. Obstet Gynecol. 2004;103(4):746–753.
  • Knudsen VK, Orozova-Bekkevold I, Rasmussen LB, et al. Low compliance with recommendations on folic acid use in relation to pregnancy: is there a need for fortification? Public Health Nutr. 2004;7(7):843–850.
  • Carmichael SL, Shaw GM, Yang W, et al. Correlates of intake of folic acid-containing supplements among pregnant women. Am J Obstet Gynecol. 2006;194(1):203–210.
  • Zeng Z, Yuan P, Wang Y, et al. Folic acid awareness and intake among women in areas with high prevalence of neural tube defects in China: a cross-sectional study. Public Health Nutr. 2011;14(7):1142–1147.
  • Viswanathan M, Treiman KA, Kish-Doto J, et al. Folic acid supplementation for the prevention of neural tube defects: an updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2017;317(2):190–203.
  • The Japanese Teratology Society. Message from the Japanese Teratology Society: proposal for supplemental intake of folic acid to reduce the risk of neural tube defects; March 27, 2018 [cited 2019 Mar 3]. Available from: http://jts.umin.jp/new/JTS_message2018_e.pdf

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.